Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Genshiro Fukuchi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Genes, Chromosomes & Cancer|August 7, 2025
Comprehensive mRNA Expressional Analysis of SMARCB1-Deficient Renal Cell Carcinoma in Patients Without HemoglobinopathiesDaisuke Kiyozawa, Genshiro Fukuchi, Takumi Miyamoto, et al.
Annals of Surgical Oncology|February 3, 2026
ASO Author Reflections: Tumor Laterality as a Key Determinant of Pelvic Lymph Node Dissection Strategy in Bladder CancerTakahiko Hajime, Masaki Shiota, Takashi Matsumoto, et al.
Annals of Surgical Oncology|January 16, 2026
Tumor Laterality Predicts Pelvic Lymph Node Metastasis Patterns in Bladder CancerTakahiko Hajime, Masaki Shiota, Genshiro Fukuchi, et al.
Virchows Archiv : an International Journal of Pathology|June 14, 2024
Papillary renal neoplasm with reverse polarity has low frequency of alterations in chromosomes 7, 17, and YDaisuke Kiyozawa, Takeshi Iwasaki, Dai Takamatsu, et al.
International Cancer Conference Journal|July 8, 2025
Complete response to pembrolizumab in mismatch repair-deficient urothelial carcinoma with local recurrence and recurrent upper tract urothelial carcinoma: a case reportKoichi Shiraishi, Masaki Shiota, Genshiro Fukuchi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2024
Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC StudyTokiyoshi Tanegashima, Masaki Shiota, Nobuhiro Fujiyama, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Genes, Chromosomes & Cancer|August 7, 2025
Comprehensive mRNA Expressional Analysis of SMARCB1-Deficient Renal Cell Carcinoma in Patients Without HemoglobinopathiesDaisuke Kiyozawa, Genshiro Fukuchi, Takumi Miyamoto, et al.
Annals of Surgical Oncology|February 3, 2026
ASO Author Reflections: Tumor Laterality as a Key Determinant of Pelvic Lymph Node Dissection Strategy in Bladder CancerTakahiko Hajime, Masaki Shiota, Takashi Matsumoto, et al.
Annals of Surgical Oncology|January 16, 2026
Tumor Laterality Predicts Pelvic Lymph Node Metastasis Patterns in Bladder CancerTakahiko Hajime, Masaki Shiota, Genshiro Fukuchi, et al.
Virchows Archiv : an International Journal of Pathology|June 14, 2024
Papillary renal neoplasm with reverse polarity has low frequency of alterations in chromosomes 7, 17, and YDaisuke Kiyozawa, Takeshi Iwasaki, Dai Takamatsu, et al.
International Cancer Conference Journal|July 8, 2025
Complete response to pembrolizumab in mismatch repair-deficient urothelial carcinoma with local recurrence and recurrent upper tract urothelial carcinoma: a case reportKoichi Shiraishi, Masaki Shiota, Genshiro Fukuchi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2024
Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC StudyTokiyoshi Tanegashima, Masaki Shiota, Nobuhiro Fujiyama, et al.
Pageof 1